ELUT
Elutia·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 1
Stock Price Surged Significantly
Consensus Rating "Strong Buy"
High Gross Profit Margin
Significant Net Income Decline
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ELUT
Elutia Inc.
A commercial-stage regenerative medicine company that develops regenerative medical products for patients undergoing surgery and receives implantable devices
Healthcare Equipment and Supplies
--
10/08/2020
NASDAQ Stock Exchange
51
12-31
Common stock
20 Firstfield Road
Gaithersburg
MD 20878
--
Elutia Inc., was incorporated in Delaware in August 2015. The company is a commercial-stage regenerative medicine company dedicated to supporting patients by providing physicians with consistent products with uniform materials, enabling surgeons to focus on achieving successful outcomes in complex surgeries.
Earnings Call
Q3/2025
Estimate EPS-0.16
Actual EPS-0.19
Estimate Revenue6.65M
Actual Revenue3.30M
Elutia's Q3 2025 Earnings Call: Contradictions Emerge on Commercial Infrastructure, Manufacturing Capacity, FDA Data Requirements, and SimpliDerm's Market Penetration
Nov 09,2025 08:20
Earnings Decrypt
Earnings Decrypt
Q1/2025
Estimate EPS--
Actual EPS-0.21
Estimate Revenue6.65M
Actual Revenue6.03M
Elutia's Q1 2025: Key Contradictions on Manufacturing, Revenue, and Cash Flow
May 19,2025 09:13
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS--
Actual EPS-0.26
Estimate Revenue6.55M
Actual Revenue6.26M
Elutia's Q2 2025: Unpacking Contradictions in Demand, Production, and Growth Strategies
Aug 14,2025 09:37
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
ELUT has released its 2025 Q3 earnings. EPS was reported at -0.19, versus the expected -0.16, missing expectations. The chart below visualizes how ELUT has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ELUT has released its 2025 Q3 earnings report, with revenue of 3.32M, reflecting a YoY change of -9.26%, and net profit of -3.87M, showing a YoY change of -400.78%. The Sankey diagram below clearly presents ELUT's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
